MUMBAI, India, Oct. 24 -- Intellectual Property India has published a patent application (202421031907 A) filed by Regrow Biosciences Private Limited, Pune, Maharashtra, on April 22, 2024, for 'method for producing mesenchymal stem cells for therapeutic applications.'
Inventor(s) include Sanghavi, Satyen; and Kedage, Vinayak.
The application for the patent was published on Oct. 24, under issue no. 43/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure relates to a method for producing mesenchymal stem cells for therapeutic applications. The method comprises culturing of MSCs to obtain 5 heterogeneous population. This heterogeneous population of MSCs were subjected to droplet encapsulation media to obtain a population of microfluidic droplets preferably comprising a single MSC; providing the population of microfluidic droplets to a microfluidics device; and identifying and selecting a homogeneous population of MSCs having medium size in the range of 15 to 30 m showing high 10 expression of cell surface markers (CD73, CD90) and increased expression of genes, such as COL12 A1; IGFBP5; THBS2; GREM1 and CDH2 genes. The MSCs having medium size are further cryopreserved to obtain a cell bank of MSCs with better stability and therapeutic potential in treating diseases like auto immune diseases. 15 20 40."
Disclaimer: Curated by HT Syndication.
